Search research articles
Contact Us
Filters
Showing results (891-900 of 991) with videos related to
Page
of 100
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2025
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer
Nicole Brighi, Daniel Wetterskog, Osvaldas Vainauskas, et al.
Immunotherapy
|
August 19, 2024
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab
Alessandra Damassi, Malvina Cremante, Alessio Signori, et al.
Clinical Genitourinary Cancer
|
January 10, 2022
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study
Daniele Raggi, Patrizia Giannatempo, Laura Marandino, et al.
Clinical Lung Cancer
|
November 9, 2020
Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy
Giannis Mountzios, Alessandro de Toma, Panagiota Economopoulou, et al.
The Oncologist
|
November 17, 2025
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis
Fabrizio Di Costanzo, Chiara Mercinelli, Alessio Signori, et al.
Clinical Genitourinary Cancer
|
November 6, 2023
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9)
Alessandra Damassi, Malvina Cremante, Alessio Signori, et al.
The Oncologist
|
August 3, 2022
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network
Pasquale Rescigno, Marco Maruzzo, Sara Elena Rebuzzi, et al.
Clinical Medicine Insights. Oncology
|
July 22, 2021
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)
Melissa Bersanelli, Sebastiano Buti, Alessio Cortellini, et al.
International Journal of Molecular Sciences
|
July 29, 2025
Genotype-Phenotype Correlation of TNF-α (-238, rs361525) and Cystatin C for Early Detection of Sepsis-Associated AKI and Its Severity in Critically Ill Neonates
Shimaa Abdelsattar, Hiba S Al-Amodi, Mahmoud Nazih, et al.
European Urology Focus
|
June 5, 2024
Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma
Cora N Sternberg, Yohann Loriot, Ernest Choy, et al.
Page
of 100
Search research articles
Search
Showing results (891-900 of 991) with videos related to
Sort By:
Page
of 100
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2025
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer
Nicole Brighi, Daniel Wetterskog, Osvaldas Vainauskas, et al.
Immunotherapy
|
August 19, 2024
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab
Alessandra Damassi, Malvina Cremante, Alessio Signori, et al.
Clinical Genitourinary Cancer
|
January 10, 2022
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study
Daniele Raggi, Patrizia Giannatempo, Laura Marandino, et al.
Clinical Lung Cancer
|
November 9, 2020
Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy
Giannis Mountzios, Alessandro de Toma, Panagiota Economopoulou, et al.
The Oncologist
|
November 17, 2025
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis
Fabrizio Di Costanzo, Chiara Mercinelli, Alessio Signori, et al.
Clinical Genitourinary Cancer
|
November 6, 2023
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9)
Alessandra Damassi, Malvina Cremante, Alessio Signori, et al.
The Oncologist
|
August 3, 2022
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network
Pasquale Rescigno, Marco Maruzzo, Sara Elena Rebuzzi, et al.
Clinical Medicine Insights. Oncology
|
July 22, 2021
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)
Melissa Bersanelli, Sebastiano Buti, Alessio Cortellini, et al.
International Journal of Molecular Sciences
|
July 29, 2025
Genotype-Phenotype Correlation of TNF-α (-238, rs361525) and Cystatin C for Early Detection of Sepsis-Associated AKI and Its Severity in Critically Ill Neonates
Shimaa Abdelsattar, Hiba S Al-Amodi, Mahmoud Nazih, et al.
European Urology Focus
|
June 5, 2024
Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma
Cora N Sternberg, Yohann Loriot, Ernest Choy, et al.
Page
of 100